Illegal Drug Approvals Could Lead To Compensation Claims

February 2007 | Legal News

Foreign drugmakers are claiming loss of earnings because Poland's pre-EU government approved a raft of domestic medicines without observing proper regulations. The action could cost the Health Ministry approximately US$1bn over the next two years, placing a significant burden on the country's under-funded healthcare system. BMI is concerned at this latest negative development to Poland's pharmaceutical market but we are maintaining our forecast for the time being. We are taking this stance primarily because any payment by the government to foreign pharmaceutical firms would invariably come from the medicines budget, a cut in which would be detrimental to the drugmakers,

If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.